http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-993739-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7ad58d3c0b071069a8ee0cb8c8ba2e8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate | 1963-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1965-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-993739-A |
| titleOfInvention | 3-acylamino-pyrazolo-(1,5-a)-benzimidazoles |
| abstract | The invention comprises 3-acylaminopyrazolo-(1,5-a)-benzimidazoles optionally substituted in the 4-position by the same acyl group present in the acylamino radical, said acyl group being derived from a carboxylic acid; and their production by acylating a 3-aminopyrazolo-(1,5-a)-benzimidazole. Suitable acylating agents are the anhydrides and chlorides of carboxylic acids such as acetic, propionic, butyric, valeric, capronic and benzoic. Examples prepare the pyrazolobenzimidazoles substituted as follows:-(1) 2-phenyl-3-acetylamino - 6 - sulphonic acid; (2) 2 - phenyl - 3-propionylamino - 6 - sulphonic acid; (3) 2-phenyl - 3 - benzoylamino - 6 - sulphonic acid; (4) 2 - methyl - 3 - acetylamino - 4 - acetyl; (5) 2 - phenyl - 3 - acetylamino; and (6) 2-methyl-3-acetylamino. The compounds of the invention exhibit central nervous system stimulation when perorally or parenterally administered to animals in a liquid or solid carrier. |
| priorityDate | 1962-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 18.